The workers at the Mayak nuclear facility near Ozyorsk, Russia are a primary source of information about exposure to radiation at low-dose rates, since they were subject to protracted exposures to external gamma rays and to internal exposures from plutonium inhalation. Here we re-examine lung cancer mortality rates and assess the effects of external gamma and internal plutonium exposures using recently developed Monte Carlo dosimetry systems. Using individual lagged mean annual lung doses computed from the dose realizations, we fit excess relative risk (ERR) models to the lung cancer mortality data for the Mayak Workers Cohort using risk-modeling software. We then used the corrected-information matrix (CIM) approach to widen the confidence intervals of ERR by taking into account the uncertainty in doses represented by multiple realizations from the Monte Carlo dosimetry systems. Findings of this work revealed that there were 930 lung cancer deaths during follow-up. Plutonium lung doses (but not gamma doses) were generally higher in the new dosimetry systems than those used in the previous analysis. This led to a reduction in the risk per unit dose compared to prior estimates. The estimated ERR/Gy for external gamma-ray exposure was 0.19 (95% CI: 0.07 to 0.31) for both sexes combined, while the ERR/Gy for internal exposures based on mean plutonium doses were 3.5 (95% CI: 2.3 to 4.6) and 8.9 (95% CI: 3.4 to 14) for males and females at attained age 60. Accounting for uncertainty in dose had little effect on the confidence intervals for the ERR associated with gamma-ray exposure, but had a marked impact on confidence intervals, particularly the upper bounds, for the effect of plutonium exposure [adjusted 95% CIs: 1.5 to 8.9 for males and 2.7 to 28 for females]. In conclusion, lung cancer rates increased significantly with both external gamma-ray and internal plutonium exposures. Accounting for the effects of dose uncertainty markedly increased the width of the confidence intervals for the plutonium dose response but had little impact on the external gamma dose effect estimate. Adjusting risk estimate confidence intervals using CIM provides a solution to the important problem of dose uncertainty. This work demonstrates, for the first time, that it is possible and practical to use our recently developed CIM method to make such adjustments in a large cohort study.
Skip Nav Destination
Close
Article navigation
Research Article|
January 20 2021
Lung Cancer in the Mayak Workers Cohort: Risk Estimation and Uncertainty Analysis
Daniel O. Stram
;
Daniel O. Stram
1
a Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California
1Address for correspondence: Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 2001 N. Soto St., Room 202D, MC: 9234, Los Angeles, CA 90033; email: stram@usc.edu.
Search for other works by this author on:
Mikhail Sokolnikov
;
Mikhail Sokolnikov
b Southern Urals Biophysics Institute, Ozyorsk, Russian Federation
Search for other works by this author on:
Bruce A. Napier
;
Bruce A. Napier
c Pacific Northwest Laboratories, Richland, Washington
Search for other works by this author on:
Vadim V. Vostrotin
;
Vadim V. Vostrotin
b Southern Urals Biophysics Institute, Ozyorsk, Russian Federation
Search for other works by this author on:
Alexander Efimov
;
Alexander Efimov
b Southern Urals Biophysics Institute, Ozyorsk, Russian Federation
Search for other works by this author on:
Dale L. Preston
Dale L. Preston
c Pacific Northwest Laboratories, Richland, Washington
Search for other works by this author on:
Radiat Res (2021)
Article history
Received:
March 31 2020
Accepted:
December 18 2020
Citation
Daniel O. Stram, Mikhail Sokolnikov, Bruce A. Napier, Vadim V. Vostrotin, Alexander Efimov, Dale L. Preston; Lung Cancer in the Mayak Workers Cohort: Risk Estimation and Uncertainty Analysis. Radiat Res 2021; doi: https://doi.org/10.1667/RADE-20-00094.1
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your Institution
20
Views
0
Citations
Citing articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner
Photon GRID Radiation Therapy: A Physics and Dosimetry White Paper from the Radiosurgery Society (RSS) GRID/LATTICE, Microbeam and FLASH Radiotherapy Working Group
Hualin Zhang, Xiaodong Wu, Xin Zhang, Sha X. Chang, Ali Megooni, Eric D. Donnelly, Mansoor M. Ahmed, Robert J. Griffin, James S. Welsh, Charles B. Simone, II, Nina A. Mayr